Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE0O2D01012
Sector:
Healthcare
Symbol:
SOTAC
Sotac Pharmaceuticals Limited
₹107.00
₹4.80
(4.70%)
▲
Prev. Close
₹102.20
Open
₹105.50
Close
₹107.00
Range
₹101.65 - ₹112.35
High
₹107.30
Low
₹105.50
Ind. Close
₹0.00
VWAP
₹106.38
The current stock price of Sotac Pharmaceuticals Limited is ₹107.00, with a target price range between ₹101.65 and ₹112.35. The stock has experienced a price change of ₹4.80 (4.70%), reflecting recent market volatility.
Today's opening price was ₹105.50, while the previous close stood at ₹102.20.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Sotac Pharmaceuticals Limited Price Chart
Sotac Pharmaceuticals Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 102.2
- Change: -102.20%
- Total Traded Volume: 0
- Total Buy Quantity: 2,400
- Total Sell Quantity: 0
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 99.00 | 1,200.00 | 0.00 |
| 99.50 | 1,200.00 | 0.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 2400
Total Sell Quantity: 0
Shareholding Patterns of Sotac Pharmaceuticals Limited
Key Trade Statistics of Sotac Pharmaceuticals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.10 |
| Traded Value (₹ Cr.) | 0.10 |
| Total Market Cap (₹ Cr.) | 118.24 |
| Free Float Market Cap (₹ Cr.) | 32.10 |
| Impact cost | N/A |
| Quantity Traded | 9,600.00 |
| Deliverable Quantity | 8,400.00 |
| % of Quantity to Traded | 87.5 |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 50 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 53.5 |
| Face Value | 10 |
Key Price Statistics of Sotac Pharmaceuticals Limited
The 52-week high for Sotac Pharmaceuticals Limited was ₹202.80, recorded on 15-Jul-2024. On the other hand, the 52-week low stands at ₹87.10, with the lowest value recorded on 05-Jun-2024.
The upper band for trading is ₹107.30, and the lower band is ₹97.10. The price band is 5%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (15-Jul-2024) | 202.80 |
| 52 Week Low (05-Jun-2024) | 87.10 |
| Upper Band | 107.30 |
| Lower Band | 97.10 |
| Price Band (%) | 5 |
| Daily Volatility | - |
| Annualised Volatility | - |
| Tick Size | 0.05 |
Key Securities Statistics of Sotac Pharmaceuticals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 13-Apr-2023 |
| Adjusted P/E | 27.89 |
| Symbol P/E | 28.48 |
| Index | NIFTY SME EMERGE |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Sotac Pharmaceuticals Limited
| Title | Details |
|---|---|
| Board Status | SME |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Sotac Pharmaceuticals Limited
| Subject | Date |
|---|---|
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 01-Mar-2025 |
| Resignation | 01-Mar-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 29-Jan-2025 |
| Appointment | 28-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 13-Jan-2025 |
| Updates | 08-Jan-2025 |
| Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter | 08-Jan-2025 |
| Reply to Clarification- Financial results | 02-Jan-2025 |
Corporate Actions of Sotac Pharmaceuticals Limited
| Face Value | Purpose | Ex-Date | ||
|---|---|---|---|---|
| No corporate actions available | ||||
Board Meetings of Sotac Pharmaceuticals Limited
Financial Results of Sotac Pharmaceuticals Limited
Company Directory of Sotac Pharmaceuticals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| - | Registered Address | Plot No. PF-21, Nr. ACME Pharma, Opp. Teva Pharma Sanand GIDC-II, Sanand AHMEDABAD - 382110 AHMEDABAD |
AHMEDABAD |
| - | Transfer Agent | Selenium Tower-B Plot 31 & 32, Gachibowli, Financial District Nanakramguda Serilingampally 500032 |
N/A |
Insider Trading of Sotac Pharmaceuticals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Sotac Pharmaceuticals Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Sotac Pharmaceuticals Limited | 2023 | 2024 | |
| Sotac Pharmaceuticals Limited | 2022 | 2023 |
Investor Complaints of Sotac Pharmaceuticals Limited
Event Calendar of Sotac Pharmaceuticals Limited
| Purpose | Details |
|---|---|
| SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. | Board Meeting Intimation |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business. | Board Meeting Intimation |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business. | Board Meeting Intimation |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 05-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Other business. | Board Meeting Intimation |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business. | Board Meeting Intimation |
| Financial Results/Other business matters | Intimation of Board meeting for consideration of Unaudited Financial Results of the Company for the Half year ended on September 30, 2023 |
| SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. | Board Meeting Intimation |
| Other business matters | For consideration of Unaudited Financial Results for quarter ended on June 30, 2023 and to consider other business matters. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
Share Transfers of Sotac Pharmaceuticals Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Sotac Pharmaceuticals Limited | 31-MAR-2024 | ||
| Sotac Pharmaceuticals Limited | 31-MAR-2023 |
Voting Results of Sotac Pharmaceuticals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 27-SEP-2024 | AGM | Adoption of Financial Statements:nTo receive, consider and adopt;n(A) The Audited Standalone Financial Statement of the Company for the Financial Year ended March 31, 2024 and the reports of the Board of Directors and Auditors thereon.nn(B) The Audited Consolidated Financial Statement of the Company for the Financial Year ended on March 31, 2024 and the report of Auditors thereon. |
| 27-SEP-2024 | AGM | Approval of the Related Party Transactions with Sotac Research Private Limited (￢ﾀﾜWholly owned Subsidiary Company￢ﾀﾝ) |
| 27-SEP-2024 | AGM | Approval of the Related Party Transactions with Sotac Lifesciences Private Limited (￢ﾀﾜSubsidiary company￢ﾀﾝ) |
| 27-SEP-2024 | AGM | Approval of the Related Party Transactions with Sotac Healthcare Private Limited (￢ﾀﾜSubsidiary company￢ﾀﾝ) |
| 27-SEP-2024 | AGM | To approve the appointment of Mr. Bhavinkumar Prafulbhai Joshi (DIN: 10236029) as a Non-Executive Independent Director of the Company for a period of 5 (five) years |
| 27-SEP-2024 | AGM | To approve the appointment of Mr. Ketankumar Arvindbhai Modi as a Non-Executive Independent Director of the Company for a period of 5 (five) years |
| 27-SEP-2024 | AGM | To ratify the remuneration payable to M/s. Suthar Haresh & Associates, Cost Accountants (FRN.: 002124) Cost Auditor of the Company for the Financial Year ended on March 31, 2025 |
| 27-SEP-2024 | AGM | To appoint a Director in place of Mr. Chetankumar Bachubhai Patel (DIN: 07252116), who retires by rotation and being eligible, offers himself for re-appointment |
| 11-SEP-2023 | AGM | To consider and adopt the Audited Standalone and consolidated Financial Statements of the Company for the Financial Year ended March 31, 2023 and the Reports of Board of Directors and Auditors thereon |
| 11-SEP-2023 | AGM | To appoint a Director in place of Mr. Vishalkumar Patel (DIN: 07252191), who retires by rotation and being eligible, offers himself for re-appointment. |
| 11-SEP-2023 | AGM | To appoint Statutory Auditors of the Company and to fix their remuneration for a term of four years. |
| 11-SEP-2023 | AGM | To Ratify remuneration payable to M/s. Suthar Haresh & Associates, Cost Accountants (Firm Registration Number: 002124) Cost Auditor, of the Company for the Financial Year ended on March 31, 2024. |
| 11-SEP-2023 | AGM | Approval of the Related Party Transactions with Sotac Healthcare Private Limited (￢ﾀﾜSubsidiary company￢ﾀﾝ). |
| 11-SEP-2023 | AGM | Approval of the Related Party Transactions with Sotac Lifesciences Private Limited (￢ﾀﾜSubsidiary company￢ﾀﾝ). |
| 11-SEP-2023 | AGM | Approval of the Related Party Transactions with Sotac Research Private Limited (￢ﾀﾜWholly owned Subsidiary Company￢ﾀﾝ). |
FAQs on Sotac Pharmaceuticals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.